BACKGROUND Scientific guidelines consider atrial fibrillation (AF) complicating degenerative mitral regurgitation (DMR) a debated indication for surgery.
D egenerative mitral regurgitation (DMR) is the most prevalent moderate/severe valvular heart disease (1) , which leads to frequent hospitalizations and cardiac surgery (2) , but often remains untreated (3) despite specific criteria defined by clinical guidelines (4, 5) . In parallel to DMR, atrial fibrillation (AF) is also prevalent with aging, is associated with notable risks, and is a burden for health care systems worldwide (6) (7) (8) (9) (10) .
Although most cases of AF are nonvalvular, DMR can cause AF because DMR-induced volume overload leads to left atrial enlargement and, eventually, AF (11, 12) .
These important epidemiological and pathophysiological data call for more effective strategies aimed at treating and possibly preventing the consequences of these 2 diseases (3) . Nowadays, innovative technologies ranging from robotic surgery to percutaneous repair or replacement can provide previously unimagined treatment opportunities, but conversely render risk assessment in DMR even more crucial (13) . Surprisingly, AF's prognostic impact in DMR remains widely debated as it is often found to be insignificant (14) (15) (16) (17) or at other times important (11, 18, 19) . These inconsistencies may be caused by small sample sizes (14, 15, 18, 20) , or single-center studies (11, 14, 15, 18) of inconsistent regurgitation etiology (14, 15, 19) , excluding medically treated patients (18, 19, 21) . The unavoidable consequences of these gaps in knowledge are that American and European guidelines on valvular diseases consider AF a Class II (debated) indication for mitral surgery, with low levels of evidence, advocating for new and more powerful studies (4, 5, 22, 23) . Furthermore, AF guidelines highlight differences between paroxysmal and persistent AF (22, 24) , raising additional uncertainties on potential outcome or therapeutic implication differences in DMR.
To address these gaps in our knowledge, a large cohort gathered at multiple international centers is needed to limit potential selection biases charac- Cox proportional hazard analysis showed that paroxysmal (adjusted HR: When CVD and non-CVD were considered in a competitive risk analysis, the independent negative prognostic implications of AF at diagnosis were retained (p # 0.001) (Online Tables 3 to 5 ). The same applied considering death and surgery as competing endpoints (Online Table 6 ). Long-term survival (left) and survival free from cardiovascular disease (CVD) (right) after surgery (Kaplan-Meier analysis). In these analyses, the observation started at the time of mitral valve operation. See also the statistical analysis section for a more detailed explanation.
AF ¼ atrial fibrillation.
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DISCUSSION
The present study used the MIDA, the largest multicenter international registry enrolling consecutive patients with pure, isolated, severe DMR diagnosed by echocardiography. We found that AF, either paroxysmal or persistent, is common at DMR diagnosis and is not an isolated phenomenon. It is asso- In routine clinical practice, DMR and AF are often diagnosed separately, but as the present study shows, the 2 pathological disorders are interlinked in many cases (11) . In addition, due to the aging and increase in the general population, the prevalence, complications, and direct costs of both conditions are expected to increase significantly in the near future (1).
About one-third of the MIDA registry patients with severe DMR in this study had a medical history remarkable for AF ( Table 1) . AF is the most common sustained cardiac arrhythmia, occurring in 1% to 2% of the general population (33,34), and DMR is another public health problem whose burden is expected to increase in line with an aging population (1) . Somewhat surprisingly, the exact prevalence of AF complicating isolated pure severe DMR is still debated, ranging in previous studies from 20% to 55% (11, 15, (18) (19) (20) (21) 35) . This is the first study providing data on the prevalence of AF at the time of DMR diagnosis derived from a large sample size collected consecutively and internationally (and, consequently, at lower risk of referral bias). By highlighting the magnitude of the epidemiological link between these 2 costly and lethal conditions (assessed by adopting the most recent diagnostic criteria) (22, 24) , our findings call for prompt preventive and therapeutic strategies aimed at properly managing this already enormous but still growing number of patients (3) .
Our study provides multiple and convergent results indicating that AF is associated with a higher risk of death. Since we recorded a more significant impairment of associated clinical/instrumental parameters in patients with AF ( Table 1) Concerning the surgical phase, we found a significantly lower rate of mitral repair performed in patients with AF compared to the repair rate obtained in patients in SR (although the overall rate of repair in the whole series was satisfactory, being almost 90%).
The lower rate of mitral repair in patients with AF has been previously reported (14) and could be attributed to the questionable perception of a diminished beneficial effect of repair over replacement in this group of patients (37, 38) . We also found a trend toward higher operative mortality in patients operated in AF, and this finding may provide additional arguments in favor of bringing forward the surgical correction to an earlier stage. Previous studies found a similar trend toward higher mortality for mitral repair when performed in patients with AF (15, 18) .
Although mitral surgery was beneficial independently of patient characteristics (Online Figure 1) , AF was nevertheless linked to an unfavorable long-term post-surgical outcome (Figures 3 and 4) , which was also confirmed at multivariate analysis (p < 0.001) and which increased moving from SR to paroxysmal to persistent AF. Current guidelines consider AF a Class II indication for surgery in DMR, reflecting current uncertainties on this topic and advocating "additional studies with focused objectives" (5, 22) .
Taken together, the results of the present study make a notable contribution in this direction.
STUDY LIMITATIONS AND STRENGTHS. We found a high prevalence of systemic hypertension in our study population. The epidemiological association between hypertension and DMR has been described, and raises the hypothesis that long-term exposure to higher blood pressure could lead to structural changes in the mitral valve (39 independently increases the risk of mortality should raise the concern that once it arises, AF increases the risk of mortality, which can only partially be reversed by surgery.
The risk of residual confounding cannot be definitively ruled out in any observational study, and the decision to recommend surgery could be linked to a subset of patients who are at lower risk (41) .
Nevertheless, surgery showed a remarkably strong independent association with total and CVD. The HR did not show significant variation, although it was 
